Search Results - "ZULFIKAR, B."

New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains by Koker, M Y, Sarper, N, Albayrak, C, Zulfikar, B, Zengin, E, Saraymen, B, Albayrak, D, Koc, B, Avcilar, H, Karakükcü, M, Chenet, C, Bianchi, F, de Brevern, A G, Petermann, R, Jallu, V

“…Glanzmann thrombasthenia (GT) is a rare autosomal recessive bleeding disorder characterized by impaired platelet aggregation due to defects in integrin αIIbβ3,…”
Get full text

Benefits of radial head excision in patients with haemophilia: mid-term functional results by Atalar, A.C., Koc, B., Birisik, F., Ersen, A., Zulfïkar, B.

“…Introduction Recurrent haemarthrosis in haemophilic patients result with arthropathy of the radiocapitellar joint and blockage of the forearm rotation. Aim The…”
Get full text

TREATMENT BURDEN AND PATIENT PREFERENCE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY by K Hampton, P Knoebl, J Odgaard-Jensen, O Stasyshyn, JJT Zaw, JS Neergaard, B Zulfikar, GG Fabbron

“…Introduction: Concizumab is a humanised, recombinant monoclonal antibody administered to patients with haemophilia A/B with inhibitors (HAwI/HBwI) as a…”
Get full text

Survival analysis of Y-90 radiosynovectomy in the treatment of haemophilic synovitis of the knee: a 10-year retrospective review by Turkmen, C., Kilicoglu, O., Dikici, F., Bezgal, F., Kuyumcu, S., Gorgun, O., Taser, O., Zulfikar, B.

“…Summary Despite recent advances including new therapeutic options and availability of primary prophylaxis in haemophiliacs, haemophilic synovitis is still the…”
Get full text

Long-term outcomes in haemophilic synovitis after radiosynovectomy using rhenium-186: a single-centre experience by Zulfikar, B., Turkmen, C., Kilicoglu, O., Dikici, F., Bezgal, F., Gorgun, O., Taser, O.

“…Summary Radiosynovectomy has been performed successfully for more than 10 years in our hospital. This study investigated the long‐term outcome in the context…”
Get full text

Oral and general health-related quality of life among young patients with haemophilia by ALPKILIÇ BASKIRT, E., AK, G., ZULFIKAR, B.

“…The clinical diagnosis of dental diseases may indicate their cause and prognosis, however it gives little information about resulting levels of impairment from…”
Get full text

The level of Ig anti‐RBD SARS‐CoV‐2 after two doses of CoronaVac vaccine by Ulhaq, Zulvikar S., Soraya, Gita V., Indriana, Kristin, Devitasari, Rizky, Pradiptha, I. Putu Yupindra, Zulfikar, Dilloniar B., Uxiana, Vita, Zulkarnain, Rachma, Lailia N., Arisanti, Ditya

Get full text

Monitoring the genotoxic effects of radiosynovectomy with Re-186 in paediatric age group undergoing therapy for haemophilic synovitis by TURKMEN, C., OZTURK, S., UNAL, S. N., ZULFIKAR, B., TASER, O., SANLI, Y., CEFLE, K., KILICOGLU, O., PALANDUZ, S., OZEL, S.

“…Purpose: The aim of this study was to investigate the genotoxic effect on the peripheral blood lymphocytes potentially induced by Re‐186 in paediatric age…”
Get full text

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study by Gringeri, A., Leissinger, C., Cortesi, P. A., Jo, H., Fusco, F., Riva, S., Antmen, B., Berntorp, E., Biasoli, C., Carpenter, S., Kavakli, K., Morfini, M., Négrier, C., Rocino, A., Schramm, W., Windyga, J., Zülfikar, B., Mantovani, L. G.

“…Summary Patients with haemophilia A and inhibitors are at high risk for severe bleeding, progression of joint disease and deterioration of health‐related…”
Get full text

Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey by Windyga, J., Dolan, G., Altisent, C., Katsarou, O., López Fernández, M.-F., Zülfikar, B.

“…Introduction Desamino D‐arginine vasopressin (DDAVP or desmopressin) is a useful and effective haemostatic treatment for patients with von Willebrand Disease…”
Get full text

Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey by Windyga, J., Dolan, G., Altisent, C., Katsarou, O., López Fernández, M.-F., Zülfikar, B.

“…Introduction The bleeding propensity in von Willebrand disease (VWD) is usually moderate or mild and patients with VWD do not need continuous treatment, but do…”
Get full text

IS A MODIFIED BFM REGIMEN WITH 1 Gram/m2 METHOTREXATE AS EFFECTIVE AS 5 Gram/m2 IN PEDIATRIC ADVANCED-STAGE NONLYMPHOBLASTIC NON-HODGKIN LYMPHOMA? by Kebudi, R., Yıldırım, U., Şenol, B., Zulfikar, B.

Get full text

057 - IS A MODIFIED BFM REGIMEN WITH 1 Gram/m2 METHOTREXATE AS EFFECTIVE AS 5 Gram/m2 IN PEDIATRIC ADVANCED-STAGE NONLYMPHOBLASTIC NON-HODGKIN LYMPHOMA? by Kebudi, R., Yıldırım, U., Şenol, B., Zulfikar, B.

Get full text

Successful management of bilateral total hip replacement in a patient with von Willebrand's disease and developmental hip dysplasia by Zülfikar, B., Akgül, T., Özdemir, N., Bezgal, F., Talu, U.

Get full text

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors by Matsushita, Tadashi, Shapiro, Amy, Abraham, Aby, Angchaisuksiri, Pantep, Castaman, Giancarlo, Cepo, Katarina, d’Oiron, Roseline, Frei-Jones, Melissa, Goh, Ai-Sim, Haaning, Jesper, Hald Jacobsen, Sanja, Mahlangu, Johnny, Mathias, Mary, Nogami, Keiji, Skovgaard Rasmussen, Josephine, Stasyshyn, Oleksandra, Tran, Huyen, Vilchevska, Kateryna, Villarreal Martinez, Laura, Windyga, Jerzy, You, Chur Woo, Zozulya, Nadezhda, Zulfikar, Bulent, Jiménez-Yuste, Victor

“…By inactivating the tissue factor pathway inhibitor, concizumab can lead to sufficient thrombin generation for clotting. In this trial, the median annualized…”
Get full text

Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey by ZÜLFIKAR, B., AYDOGAN, G., SALCIOGLU, Z., ONER, A. F., KAVAKLI, K., GURSEL, T., ZÜLFIKAR, H.

“…Long used in established industrialized nations to treat patients with haemophilia and inhibitors, factor eight inhibitor bypassing activity (FEIBA) has, in…”
Get full text

Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency by Büyükkapu Bay, Sema, Kebudi, Rejin, Zülfikar, Bülent

“…Malignant melanoma is very rare in childhood. The approach to diagnosis and treatment in children has been adopted from adult guidelines. Vemurafenib is…”
Get full text

Circumcision ceremonies at the Ottoman Palace by Sari, Nil, Cenk Büyükünal, S.N, Zülfikar, Bedizel

“…Circumcision is widely practiced in all Islamic countries. Festivities pertaining to circumcision vary according to the regions and civilizations. In this…”
Get full text

Two patients with haemophilia and acute leukaemia by Zülfi̇kar, B.

“…Acute leukaemia is the commonest form of malignancy in childhood. The coincidental development of leukaemia in children or adults with haemophilia is extremely…”
Get full text

LB 01.1 Efanesoctocog Alfa Prophylaxis for Previously Treated Patients <12 Years of Age with Severe Hemophilia A by Malec, L., Peyvandi, F., Chan, A., Koenigs, C., Zulfikar, B., Yuan, H., Simpson, M., Alvarez-Román, M., Carcao, M., Staber, J., Dunn, A., Chou, S., D’Oiron, R., Albisetti, M., Demissie, M., Santagostino, E., Yarramaneni, A., Abad-Franch, L., Gunawardena, S., Fijnvandraat, K.

Get full text